The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy

Clinical trial NCT06597539 · RECRUITING

Trial details

NCT number: NCT06597539
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatobiliary Malignancy

Start date: 2024-11-09
Primary completion: 2026-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.